Cisplatin target
WebCisplatin (DDP) is a common therapeutic option for non‐small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. ... Aptamer‐targeted nano‐zinc carriers were loaded with USP14 siRNA to target DDP ... WebJan 10, 2024 · Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer Authors
Cisplatin target
Did you know?
WebCisplatin is a member of the alkylating agents drug class and is commonly used for Anal Cancer, Bladder Cancer, Blood Cell Transplantation, and others. ... , Target, WalMart … WebCisplatin is a chemotherapy drug which is used to treat cancers including: sarcoma, small cell lung cancer, germ cell tumors, lymphoma, and ovarian cancer. While it is often …
WebApr 13, 2024 · Bonn researchers uncover contribution of protein degradation processes to cisplatin resistance in germ cell tumors: Cisplatin is used successfully in the … Web2 days ago · Testicular cancer, also known as testicular germ cell tumors (TGCT), is the most common type of cancer in young men. When treated with cisplatin, the tumor cells …
WebApr 13, 2024 · Testicular cancer, also known as testicular germ cell tumors (TGCT), is the most common type of cancer in young men. When treated with cisplatin, the tumor cells stop growing and die. This is because the cytostatic drug causes damage to DNA, the carrier of genetic information, thus stopping the cell cycle. "The alarm signal is sent … WebCisplatin is a chemotherapy drug. You might have it as a treatment for a number of different types of cancer. You might have cisplatin on its own or in combination with other cancer …
WebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying …
WebFeb 16, 2024 · severe or ongoing nausea and vomiting; vision problems, pain behind your eyes; hearing problems, ringing in your ears; pain, redness, swelling, or skin changes … chromosome 15q24 microdeletion syndromeWebJul 1, 2024 · The main target of cisplatin is genomic DNA (gDNA) but a very little amount (∼1%) of intercellular cisplatin is generally bound to gDNA [58]. Several proteins like … chromosome 16p11.2 deletion syndrome icd 10WebThe cellular uptake of cisplatin and its targets. Reprinted with permission. 1. As seen in Figure 1, once inside the cell, cisplatin has a number of possible targets: DNA; RNA; … chromosome 15 tay sachsWebJan 13, 2011 · Cisplatin is one of the most effective chemotherapeutic agents against many forms of cancer including testicular, bladder, head and neck, ovarian, breast, lung, … chromosome 16 inversionWebNov 11, 2008 · The ability of cis-diamminedichloroplatinum(II), cisplatin (9, 10), to inhibit the growth of cancer cells by interfering with transcription and other DNA-mediated cellular functions has been elucidated over the past 30 years.Cisplatin is highly effective against several forms of cancer, most notably testicular tumors, and it is also commonly used to … chromosome 15 genesWebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. ... Aptamer-targeted nano-zinc carriers were loaded with USP14 siRNA to target DDP ... chromosome 16p duplicationWebCisplatin is a chemotherapeutic drug that has been used in the treatment of various types of human cancers such as ovarian, lung, head and neck, testicular and bladder. Cisplatin … chromosome 17 abnormalities